National Institutes of Health logo
National Institutes of Health

Accelerating Research and Development of Next Generation Malaria Vaccines Against Malaria - A Model for Mosquito-Borne Diseases

Funds basic and preclinical research toward more effective malaria vaccines, designed as a model for other mosquito-borne diseases too.

Malaria vaccines exist, but none of them stop the disease well enough on their own. This funds the research trying to change that — and it treats malaria as a proving ground for vaccine science that could reach beyond it.

The National Institute of Allergy and Infectious Diseases wants basic research, discovery work and preclinical development aimed at a genuinely more effective malaria vaccine. I

Basic research, discovery and preclinical development of more effective malaria vaccines, using approaches such as structure-based immunogen design and combination vaccines that address parasite infection or disease burden, with malaria treated as a model whose findings should extend to other mosquito-borne diseases.

CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.One-off
Next deadlineiThe next date applications are due. Rolling means you can apply any time.11 Feb 2027
Decision timeiTypical time from the deadline to the funder's decision.26 weeks
Project durationiHow long the funded work is expected to run.
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.
Funding pooliThe total budget available across all awards in this round.

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Last verified: 25 Aug 2026Funder reference: RFA-AI-28-024Source: www.grants.gov